Table 1.

Genetic subtypes of JMML

I. Somatic PTPN11 mutation 
 • Rapidly fatal without allogeneic HSCT 
 • High probability of relapse 
 • Frequent acquisition of NF1 haploinsufficiency 
II. Somatic NRAS mutation 
 • Heterogeneous subtype 
 • Rapid progress with high relapse rate after HSCT, typically in older children with high levels of HbF 
 • Indolent course with spontaneous regression, typically in infants or in cases with G12S mutation 
III. Somatic KRAS mutation 
 • Mostly infants 
 • Frequent association with monosomy 7 
 • Aggressive at presentation but low risk of relapse after allogeneic HSCT 
IV. JMML in children with NF1 
 • Older age at diagnosis 
 • Higher platelet count 
 • Higher percentage of BM blasts 
 • Fatal without allogeneic HSCT 
V. JMML in children with germline CBL mutation 
 • Loss of CBL heterozygosity in hematopoietic cells 
 • Absence of concomitant mutations 
 • Value of allogeneic HSCT uncertain 
 • Frequent occurrence of mixed chimerism after allogeneic HSCT 
I. Somatic PTPN11 mutation 
 • Rapidly fatal without allogeneic HSCT 
 • High probability of relapse 
 • Frequent acquisition of NF1 haploinsufficiency 
II. Somatic NRAS mutation 
 • Heterogeneous subtype 
 • Rapid progress with high relapse rate after HSCT, typically in older children with high levels of HbF 
 • Indolent course with spontaneous regression, typically in infants or in cases with G12S mutation 
III. Somatic KRAS mutation 
 • Mostly infants 
 • Frequent association with monosomy 7 
 • Aggressive at presentation but low risk of relapse after allogeneic HSCT 
IV. JMML in children with NF1 
 • Older age at diagnosis 
 • Higher platelet count 
 • Higher percentage of BM blasts 
 • Fatal without allogeneic HSCT 
V. JMML in children with germline CBL mutation 
 • Loss of CBL heterozygosity in hematopoietic cells 
 • Absence of concomitant mutations 
 • Value of allogeneic HSCT uncertain 
 • Frequent occurrence of mixed chimerism after allogeneic HSCT 
Close Modal

or Create an Account

Close Modal
Close Modal